Illumina Body Map 2 (GSE30611)
Name | miRBASE accession |
---|---|
hsa-miR-24-3p
|
MIMAT0000080 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_86991135 Show fit | 2.49 |
ENST00000398399.7
|
vestigial like family member 3 |
|
chr17_-_63700100 Show fit | 2.10 |
ENST00000578993.5
ENST00000259006.8 ENST00000583211.5 |
LIM domain containing 2 |
|
chr14_+_22836574 Show fit | 2.02 |
ENST00000548162.2
ENST00000311852.11 |
matrix metallopeptidase 14 |
|
chr2_-_216695540 Show fit | 1.95 |
ENST00000233813.5
|
insulin like growth factor binding protein 5 |
|
chr7_+_5592805 Show fit | 1.88 |
ENST00000382361.8
|
fascin actin-bundling protein 1 |
|
chr5_-_173328407 Show fit | 1.72 |
ENST00000265087.9
|
stanniocalcin 2 |
|
chr9_+_111896804 Show fit | 1.69 |
ENST00000374279.4
|
UDP-glucose ceramide glucosyltransferase |
|
chr10_-_33334625 Show fit | 1.56 |
ENST00000374875.5
ENST00000374822.8 ENST00000374867.7 |
neuropilin 1 |
|
chr5_-_150155828 Show fit | 1.51 |
ENST00000261799.9
|
platelet derived growth factor receptor beta |
|
chr5_-_172188185 Show fit | 1.51 |
ENST00000176763.10
|
serine/threonine kinase 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.2 | 2.0 | GO:1990834 | response to odorant(GO:1990834) |
0.2 | 2.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 1.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.7 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 1.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 1.6 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.5 | 1.5 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.0 | 1.5 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.4 | 1.3 | GO:0003192 | mitral valve formation(GO:0003192) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 5.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 2.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 2.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 2.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 2.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 2.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 2.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 1.9 | GO:0044393 | microspike(GO:0044393) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 1.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 2.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 1.7 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 1.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 1.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 1.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 3.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 3.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 3.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 2.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 2.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 2.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |